[8-K] Nutex Health, Inc. Reports Material Event

Rhea-AI Filing Summary

Nutex Health Inc. reported that it has released its financial and operating results for the first quarter ended March 31, 2025. The company announced these results on November 18, 2025 and made them available through a press release furnished as an exhibit to this report. The press release, dated November 14, 2025, is provided as Exhibit 99.1 and contains the detailed figures and operational updates for the quarter.

The company also clarified that the information in this results announcement, including the press release, is being furnished rather than filed, meaning it is not automatically incorporated into other securities law filings unless specifically referenced.

Insights

Equity research analyst

Nutex Health released Q1 2025 results via a furnished press release.

Nutex Health Inc. disclosed that it has issued its financial and operating results for the first quarter ended March 31, 2025, with the announcement made on November 18, 2025. The detailed numbers and commentary are contained in a press release dated November 14, 2025, attached as Exhibit 99.1.

The company states that this results information is being "furnished" rather than "filed" under securities laws. That distinction typically limits how the information is incorporated into other regulatory documents, while still making the earnings details available to the market.

Because the actual revenue and earnings figures are contained only in the press release exhibit, the broader impact on the company’s outlook depends on the specific metrics and trends discussed there, which are not detailed in this summary-level disclosure.

0001479681FALSE00014796812025-11-182025-11-18

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported) November 18, 2025

NUTEX HEALTH INC.

(Exact name of registrant as specified in its charter)

Delaware			001-41346			11-3363609
(State or Other Jurisdiction of Incorporation)			(Commission File Number)			(I.R.S. Employer Identification Number)

6030 S. Rice Ave, Suite C, Houston, Texas 77081

(Address of principal executive offices) (zip code)

(713) 660-0557

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o   Precommencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o   Precommencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbols(s)			Name of each exchange on which registered
Common Stock, $0.001 par value			NUTX			NASDAQ Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Item 2.02. Results of Operations and Financial Condition

On November 18, 2025, Nutex Health Inc. (the “Company”) announced its financial and operating results for the first quarter ending March 31, 2025. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits

(d)Exhibits

Exhibit No.			Description of Exhibit
99.1			Press Release dated November 14, 2025
104			Cover Page Interactive Data File - the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

THE INFORMATION CONTAINED IN ITEM 2.02 OF THIS CURRENT REPORT, INCLUDING EXHIBIT 99.1 ATTACHED HERETO, SHALL NOT BE DEEMED “FILED” FOR THE PURPOSES OF SECTION 18 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED, NOR SHALL IT BE DEEMED INCORPORATED BY REFERENCE INTO ANY REGISTRATION STATEMENT OR OTHER FILING PURSUANT TO THE SECURITIES ACT OF 1933, AS AMENDED, EXCEPT AS OTHERWISE EXPRESSLY STATED IN SUCH FILING

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: November 18, 2025

Nutex Health Inc.

By: /s/ Jon C. Bates

Jon C. Bates

Chief Financial Officer

FAQ

What did Nutex Health (NUTX) announce in this Form 8-K?

Nutex Health Inc. announced that it has released its financial and operating results for the first quarter ended March 31, 2025. The detailed results are contained in a press release attached as Exhibit 99.1.

Where can investors find Nutex Health's Q1 2025 financial details?

The specific financial figures and operating metrics for Q1 2025 are included in Nutex Health's press release dated November 14, 2025, which is furnished as Exhibit 99.1 to this report.

How is the Nutex Health Q1 2025 results information treated under securities laws?

The company states that the information in Item 2.02, including Exhibit 99.1, is being furnished and not deemed "filed" under the Securities Exchange Act of 1934, unless expressly incorporated into another filing.

What period does Nutex Health's latest results cover?

The announced financial and operating results cover Nutex Health's first quarter ending March 31, 2025.

When did Nutex Health announce its Q1 2025 results?

Nutex Health announced its first quarter 2025 results on November 18, 2025, and referenced a press release dated November 14, 2025 that contains the detailed information.

Who signed the Nutex Health Form 8-K for the Q1 2025 results?

The report was signed on behalf of Nutex Health Inc. by Jon C. Bates, Chief Financial Officer, dated November 18, 2025.